Spectral Correlates of Impulsivity in Patients With Traumatic Brain Injury

NCT ID: NCT04239274

Last Updated: 2022-01-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-01

Study Completion Date

2021-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Transcranial electrical stimulation (tES) is a non-invasive form of brain stimulation that has previously been to shown to have therapeutic potential in traumatic brain injury (TBI) patients. In this study, the study team will use a brain activity monitor (electroencephalogram, EEG) and a computer-based task to observe the effects of different forms of tES, like transcranial direct current stimulation (tDCS) and transcranial pulsed current stimulation (tPCS), on impulse control and sustained attention in people with TBI. Additionally, the study team will measure how much tDCS and tPCS affect the brain activity of a specific area of the brain associated with impulse control and attention. Problems with response inhibition have been shown to make rehabilitation more difficult for people with TBI. It also reduces social functioning and can also negatively affect job performance, which ultimately lead to a decreased quality of life. A better understanding of the effects of tES in TBI patients could be informative in finding out what its therapeutic potential is for this population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Traumatic Brain Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Transcranial Direct Current Stimulation (tDCS)

Group Type EXPERIMENTAL

transcranial direct current stimulation

Intervention Type DEVICE

Subjects in this arm will receive one session of tDCS for 20 minutes at 2.0 milliamps.

Transcranial Pulsed Stimulation tPCS

Group Type EXPERIMENTAL

transcranial pulsed current stimulation

Intervention Type DEVICE

Subjects in this arm will receive one session of tPCS for 20 minutes at 2.0 milliamps.

No Stimulation

Group Type SHAM_COMPARATOR

Sham-no stimulation

Intervention Type DEVICE

Subjects in this arm will receive one session of sham for 20 minutes.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

transcranial direct current stimulation

Subjects in this arm will receive one session of tDCS for 20 minutes at 2.0 milliamps.

Intervention Type DEVICE

transcranial pulsed current stimulation

Subjects in this arm will receive one session of tPCS for 20 minutes at 2.0 milliamps.

Intervention Type DEVICE

Sham-no stimulation

Subjects in this arm will receive one session of sham for 20 minutes.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects referred to the PI for management of TBI
* Subject is at least 3 months post-injury at the time of consent
* Ages 25-70

Exclusion Criteria

* Subjects with the inability to consent for themselves
* Subjects with body habitus that does not allow the EEG cap to be properly placed
* Presence of scalp injury or disease
* Allergic reaction to topical lidocaine jelly
* Prior intracranial surgery or skull-fracture over VLPFC
* Presence of hemorrhage on intracranial imaging
* Prior brain radiotherapy
* Prior history of intracranial tumor, intracranial infection, or cerebrovascular malformation
* Subjects with the inability to see and read from a computer screen
* History of any form of seizures prior to TBI or within 6 months of study participation
* Pregnancy
Minimum Eligible Age

25 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of South Carolina

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nathan Rowland

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nathan Rowland, MD,PhD

Role: PRINCIPAL_INVESTIGATOR

Medical University of South Carolina

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

00093356

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Brain Stimulation for Mild Traumatic Brain Injury
NCT02292589 ACTIVE_NOT_RECRUITING PHASE2
TMS With Real-time E-field and EEG Source Imaging
NCT06645613 NOT_YET_RECRUITING NA
Spectral Correlation Coefficient-based TMS
NCT04040062 ENROLLING_BY_INVITATION NA